- Home
- CPAC vs FULC Comparison
CPAC vs FULC Comparison
Compare CPAC & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPAC
- FULC
- Stock Information
- Founded
- CPAC 1949
- FULC 2015
- Country
- CPAC Peru
- FULC United States
- Employees
- CPAC N/A
- FULC N/A
- Industry
- CPAC Building Materials
- FULC Biotechnology: Pharmaceutical Preparations
- Sector
- CPAC Industrials
- FULC Health Care
- Exchange
- CPAC Nasdaq
- FULC Nasdaq
- Market Cap
- CPAC 580.5M
- FULC 469.0M
- IPO Year
- CPAC 2012
- FULC 2019
- Fundamental
- Price
- CPAC $7.29
- FULC $9.50
- Analyst Decision
- CPAC Sell
- FULC Buy
- Analyst Count
- CPAC 2
- FULC 7
- Target Price
- CPAC $6.95
- FULC $10.43
- AVG Volume (30 Days)
- CPAC 19.0K
- FULC 694.7K
- Earning Date
- CPAC 10-28-2025
- FULC 10-29-2025
- Dividend Yield
- CPAC 6.89%
- FULC N/A
- EPS Growth
- CPAC 20.27
- FULC N/A
- EPS
- CPAC 0.15
- FULC N/A
- Revenue
- CPAC $601,081,883.00
- FULC N/A
- Revenue This Year
- CPAC $9.96
- FULC N/A
- Revenue Next Year
- CPAC $1.70
- FULC N/A
- P/E Ratio
- CPAC $9.59
- FULC N/A
- Revenue Growth
- CPAC 6.18
- FULC 2752.05
- 52 Week Low
- CPAC $5.10
- FULC $2.32
- 52 Week High
- CPAC $7.57
- FULC $10.11
- Technical
- Relative Strength Index (RSI)
- CPAC 52.78
- FULC 60.27
- Support Level
- CPAC $7.16
- FULC $7.51
- Resistance Level
- CPAC $7.40
- FULC $9.05
- Average True Range (ATR)
- CPAC 0.19
- FULC 0.84
- MACD
- CPAC -0.02
- FULC 0.05
- Stochastic Oscillator
- CPAC 29.88
- FULC 85.66
About CPAC Cementos Pacasmayo S.A.A. (Each representing five)
Cementos Pacasmayo SAA is a Peruvian cement company that produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production and transportation facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.